questionsmedicales.fr
Maladies de la peau et du tissu conjonctif
Maladies de la peau
Dermatoses vasculaires
Dermatoses vasculaires : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Dermatoses vasculaires : Questions médicales les plus fréquentes",
"headline": "Dermatoses vasculaires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Dermatoses vasculaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-11",
"dateModified": "2025-03-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Dermatoses vasculaires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies de la peau",
"url": "https://questionsmedicales.fr/mesh/D012871",
"about": {
"@type": "MedicalCondition",
"name": "Maladies de la peau",
"code": {
"@type": "MedicalCode",
"code": "D012871",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Angiomatose bacillaire",
"alternateName": "Angiomatosis, Bacillary",
"url": "https://questionsmedicales.fr/mesh/D016917",
"about": {
"@type": "MedicalCondition",
"name": "Angiomatose bacillaire",
"code": {
"@type": "MedicalCode",
"code": "D016917",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.862.060"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Behçet",
"alternateName": "Behcet Syndrome",
"url": "https://questionsmedicales.fr/mesh/D001528",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Behçet",
"code": {
"@type": "MedicalCode",
"code": "D001528",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.862.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vasculopathie livédoïde",
"alternateName": "Livedoid Vasculopathy",
"url": "https://questionsmedicales.fr/mesh/D000090122",
"about": {
"@type": "MedicalCondition",
"name": "Vasculopathie livédoïde",
"code": {
"@type": "MedicalCode",
"code": "D000090122",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.862.406"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Maladie de Raynaud",
"alternateName": "Raynaud Disease",
"url": "https://questionsmedicales.fr/mesh/D011928",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Raynaud",
"code": {
"@type": "MedicalCode",
"code": "D011928",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.862.406.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Papulose atrophiante maligne",
"alternateName": "Malignant Atrophic Papulosis",
"url": "https://questionsmedicales.fr/mesh/D054853",
"about": {
"@type": "MedicalCondition",
"name": "Papulose atrophiante maligne",
"code": {
"@type": "MedicalCode",
"code": "D054853",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.862.457"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Kawasaki",
"alternateName": "Mucocutaneous Lymph Node Syndrome",
"url": "https://questionsmedicales.fr/mesh/D009080",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Kawasaki",
"code": {
"@type": "MedicalCode",
"code": "D009080",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.862.560"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Polyartérite noueuse",
"alternateName": "Polyarteritis Nodosa",
"url": "https://questionsmedicales.fr/mesh/D010488",
"about": {
"@type": "MedicalCondition",
"name": "Polyartérite noueuse",
"code": {
"@type": "MedicalCode",
"code": "D010488",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.862.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome de Sneddon",
"alternateName": "Sneddon Syndrome",
"url": "https://questionsmedicales.fr/mesh/D018860",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Sneddon",
"code": {
"@type": "MedicalCode",
"code": "D018860",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.862.775"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Takayashu",
"alternateName": "Takayasu Arteritis",
"url": "https://questionsmedicales.fr/mesh/D013625",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Takayashu",
"code": {
"@type": "MedicalCode",
"code": "D013625",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.862.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Dermatoses vasculaires",
"alternateName": "Skin Diseases, Vascular",
"code": {
"@type": "MedicalCode",
"code": "D017445",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Thomas Mentzel",
"url": "https://questionsmedicales.fr/author/Thomas%20Mentzel",
"affiliation": {
"@type": "Organization",
"name": "Pathologist, Dermatopathology Department, Dermatopathologie Bodensee, Friedrichshafen, Germany; and."
}
},
{
"@type": "Person",
"name": "Martina M Sanchez",
"url": "https://questionsmedicales.fr/author/Martina%20M%20Sanchez",
"affiliation": {
"@type": "Organization",
"name": "Departments of Bioengineering, University of California."
}
},
{
"@type": "Person",
"name": "Joshua T Morgan",
"url": "https://questionsmedicales.fr/author/Joshua%20T%20Morgan",
"affiliation": {
"@type": "Organization",
"name": "Departments of Bioengineering, University of California; jmorgan@engr.ucr.edu."
}
},
{
"@type": "Person",
"name": "Hans-Uwe Simon",
"url": "https://questionsmedicales.fr/author/Hans-Uwe%20Simon",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pharmacology, University of Bern, Bern, Switzerland."
}
},
{
"@type": "Person",
"name": "Dagmar Simon",
"url": "https://questionsmedicales.fr/author/Dagmar%20Simon",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. dagmar.simon@insel.ch."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Prostate and metastasis-directed focal therapy in prostate cancer: hype or hope?",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36718727",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14737140.2023.2171991"
}
},
{
"@type": "ScholarlyArticle",
"name": "The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men.",
"datePublished": "2023-05-02",
"url": "https://questionsmedicales.fr/article/37534902",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4103/aja20239"
}
},
{
"@type": "ScholarlyArticle",
"name": "Simultaneous thulium laser resection of the prostate and transperineal prostate biopsy in clinically diagnosed metastatic prostate cancer with bladder outlet obstruction.",
"datePublished": "2023-08-18",
"url": "https://questionsmedicales.fr/article/37596454",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10103-023-03848-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Staging Prostate Cancer with",
"datePublished": "2023-04-28",
"url": "https://questionsmedicales.fr/article/37116912",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2967/jnumed.122.265371"
}
},
{
"@type": "ScholarlyArticle",
"name": "Complexities of Prostate Cancer.",
"datePublished": "2022-11-17",
"url": "https://questionsmedicales.fr/article/36430730",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms232214257"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de la peau et du tissu conjonctif",
"item": "https://questionsmedicales.fr/mesh/D017437"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies de la peau",
"item": "https://questionsmedicales.fr/mesh/D012871"
},
{
"@type": "ListItem",
"position": 4,
"name": "Dermatoses vasculaires",
"item": "https://questionsmedicales.fr/mesh/D017445"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Dermatoses vasculaires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Dermatoses vasculaires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Dermatoses vasculaires",
"description": "Comment diagnostique-t-on une dermatoses vasculaire ?\nQuels tests sont utilisés pour évaluer les dermatoses vasculaires ?\nLes dermatoses vasculaires nécessitent-elles des examens sanguins ?\nQuels signes cliniques indiquent une dermatoses vasculaire ?\nPeut-on confondre les dermatoses vasculaires avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Prostatic+Neoplasms&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Dermatoses vasculaires",
"description": "Quels sont les symptômes courants des dermatoses vasculaires ?\nLes dermatoses vasculaires provoquent-elles des douleurs ?\nLes dermatoses vasculaires peuvent-elles causer des saignements ?\nY a-t-il des symptômes systémiques associés ?\nLes démangeaisons sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Prostatic+Neoplasms&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Dermatoses vasculaires",
"description": "Comment prévenir les dermatoses vasculaires ?\nL'hydratation de la peau est-elle importante ?\nLes vêtements peuvent-ils aider à prévenir ces affections ?\nFaut-il éviter certains aliments ?\nLe stress influence-t-il les dermatoses vasculaires ?",
"url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Prostatic+Neoplasms&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Dermatoses vasculaires",
"description": "Quels traitements sont disponibles pour les dermatoses vasculaires ?\nLes corticostéroïdes sont-ils efficaces ?\nQuand faut-il envisager une intervention chirurgicale ?\nLes traitements naturels sont-ils recommandés ?\nLes lasers sont-ils efficaces pour traiter ces affections ?",
"url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Prostatic+Neoplasms&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Dermatoses vasculaires",
"description": "Quelles complications peuvent survenir ?\nLes dermatoses vasculaires peuvent-elles affecter la qualité de vie ?\nY a-t-il un risque de cancer associé ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Prostatic+Neoplasms&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Dermatoses vasculaires",
"description": "Quels sont les principaux facteurs de risque ?\nLe tabagisme est-il un facteur de risque ?\nL'exposition au soleil influence-t-elle ces affections ?\nLe stress est-il un facteur de risque ?\nLes maladies chroniques augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D017445?mesh_terms=Prostatic+Neoplasms&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une dermatoses vasculaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et parfois des biopsies cutanées."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les dermatoses vasculaires ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme l'échographie Doppler et l'angiographie peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Les dermatoses vasculaires nécessitent-elles des examens sanguins ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens sanguins peuvent être réalisés pour évaluer des troubles sous-jacents."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une dermatoses vasculaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des rougeurs, des ecchymoses ou des lésions vasculaires visibles peuvent indiquer une affection."
}
},
{
"@type": "Question",
"name": "Peut-on confondre les dermatoses vasculaires avec d'autres maladies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être confondues avec des maladies comme le psoriasis ou l'eczéma."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des dermatoses vasculaires ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des rougeurs, des démangeaisons, et des lésions cutanées."
}
},
{
"@type": "Question",
"name": "Les dermatoses vasculaires provoquent-elles des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent provoquer des douleurs, surtout si les lésions sont enflammées."
}
},
{
"@type": "Question",
"name": "Les dermatoses vasculaires peuvent-elles causer des saignements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines peuvent entraîner des saignements, notamment les télangiectasies."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fièvre ou la fatigue peuvent survenir dans certains cas."
}
},
{
"@type": "Question",
"name": "Les démangeaisons sont-elles fréquentes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les démangeaisons sont un symptôme fréquent des dermatoses vasculaires."
}
},
{
"@type": "Question",
"name": "Comment prévenir les dermatoses vasculaires ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les facteurs de risque comme l'exposition au soleil et le tabagisme peut aider."
}
},
{
"@type": "Question",
"name": "L'hydratation de la peau est-elle importante ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir la peau hydratée peut réduire le risque d'irritation et de lésions."
}
},
{
"@type": "Question",
"name": "Les vêtements peuvent-ils aider à prévenir ces affections ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, porter des vêtements protecteurs peut réduire l'exposition aux irritants."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certains aliments ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines personnes peuvent bénéficier d'un régime anti-inflammatoire pour réduire les symptômes."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il les dermatoses vasculaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut aggraver les symptômes, donc des techniques de gestion du stress sont utiles."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les dermatoses vasculaires ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des crèmes topiques, des lasers et parfois des médicaments oraux."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corticostéroïdes peuvent réduire l'inflammation et les symptômes cutanés."
}
},
{
"@type": "Question",
"name": "Quand faut-il envisager une intervention chirurgicale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une intervention chirurgicale est envisagée pour les cas graves ou réfractaires aux traitements."
}
},
{
"@type": "Question",
"name": "Les traitements naturels sont-ils recommandés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains traitements naturels peuvent aider, mais il est important de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Les lasers sont-ils efficaces pour traiter ces affections ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les lasers peuvent réduire l'apparence des lésions vasculaires et améliorer l'esthétique."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des infections ou des cicatrices peuvent survenir si non traitées."
}
},
{
"@type": "Question",
"name": "Les dermatoses vasculaires peuvent-elles affecter la qualité de vie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des problèmes psychologiques et affecter l'estime de soi."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de cancer associé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines dermatoses vasculaires peuvent avoir un risque accru de cancer cutané."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications ne sont pas fréquentes mais peuvent survenir dans des cas graves."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite souvent une approche multidisciplinaire et un suivi régulier."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe féminin, et des antécédents familiaux de dermatoses."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut aggraver les dermatoses vasculaires et augmenter les symptômes."
}
},
{
"@type": "Question",
"name": "L'exposition au soleil influence-t-elle ces affections ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition excessive au soleil peut aggraver les dermatoses vasculaires."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les symptômes et augmenter le risque de dermatoses."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies chroniques, comme le diabète, peuvent augmenter le risque de dermatoses."
}
}
]
}
]
}
The paradigm of focal therapy's role in metastatic patients is being challenged by evolving attitudes and emerging data. At the current time, specifically regarding prostate cancer, does the evidence ...
We searched the literature via PubMed, MEDLINE, and Embase for studies from 2014 to the present addressing focal therapy with non-palliative intent in metastatic prostate cancer patients, emphasizing ...
Current evidence is strongest, and in our opinion practice-changing, for prostate-directed RT in de novo metastatic patients with low metastatic burden. Metastasis-directed therapy with SBRT is consis...
Using prostate-specific antigen (PSA) for prostate cancer (PCa) screening led to overinvestigation and overdiagnosis of indolent PCa. We aimed to investigate the value of prostate health index (PHI) a...
Metastatic prostate cancer (mPCa) patients complicated with bladder outlet obstruction (BOO) are often referred to a urologist. Androgen deprivation therapy (ADT) combined with indwelling catheter usu...
Although prostate-specific membrane antigen (PSMA) PET/CT has been shown valuable for staging biopsy-proven [B(+)] high-risk prostate cancer, elderly patients are occasionally referred for PSMA PET/CT...
Prostate cancer has a long disease history and a wide variety and uncertainty in individual patients' clinical progress. In recent years, we have seen a revolutionary advance in both prostate cancer p...
There is a clinical need to identify patients with an elevated PSA who would benefit from prostate biopsy due to the presence of clinically significant prostate cancer (CSCaP). We have previously repo...
To further develop and adapt the MiCheck® Prostate test so it can be performed using a standard clinical chemistry analyzer and characterize its performance using the MiCheck-01 clinical trial sample ...
About 358 patient samples from the MiCheck-01 US clinical trial were used for the development of the MiCheck® Prostate test. These consisted of 46 controls, 137 non-CaP, 62 non-CSCaP, and 113 CSCaP....
Serum analyte concentrations for cellular growth factors were determined using custom-made Luminex-based R&D Systems multi-analyte kits. Analytes that can also be measured using standard chemistry ana...
Logistic regression modeling with Monte Carlo cross-validation was used to identify Human Epidydimal Protein 4 (HE4) as an analyte able to significantly improve the algorithm specificity at 95% sensit...
The MiCheck® logistic regression model was developed and consisted of PSA, %free PSA, DRE, and HE4. The model differentiated clinically significant cancer from no cancer or not-clinically significant ...
The MiCheck® Prostate test identifies clinically significant prostate cancer with high sensitivity and negative predictive value (NPV). It can be performed in a clinical laboratory using a Roche Cobas...
Prostate health index (PHI) and, more recently, Proclarix have been proposed as serum biomarkers for prostate cancer (PCa). In this study, we aimed to evaluate Proclarix and PHI for predicting clinica...
Proclarix and PHI were measured using samples of 344 men from two different centers. All patients underwent prostate biopsy, and among those, 188 men with PCa on biopsy had an additional radical prost...
The cohort median age and PSA were 65 (interquartile range [IQR]: 60-71) and 5.6 (IQR: 4.3-7.2) ng/ml, respectively. CsPCa was diagnosed in 161 (47%) men based on the RP specimen. ROC analysis showed ...
Results of this study show that both Proclarix and PHI accurately detect the presence of csPCa. The model combining Proclarix and PHI revealed the synergistic effect and improved the diagnostic perfor...
Transperineal (TP) multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has been shown to detect more clinically significant (cs) prostate cancer (PCa) than standard template biops...
We identified all men who with suspicious lesions on mpMRI and underwent TP TBx (3-core) and concomitant SBx (20-core) in our single hospital from September 2019 to February 2021. Clinical, MRI and bi...
Three hundred and one (n = 301) men were included. The median prostate volume by MRI was 45 ml. The patients were divided by prostate volume into three groups: ≤30ml group (19.9%), >30 to ≤45 ml group...
Our data suggest that performing TBx with limited additional cores may potentially achieve the same csPCa detection rate as the combined SBx and TBx in smaller prostates....
We sought to determine whether two soluble forms with different size of mtDNA are linked to prostatic inflammation, and whether they discriminate prostate cancer (PCa) from inflammatory prostatic cond...
Histopathologically diagnosed prostatitis, PCa and benign prostatic hyperplasia patients (n = 93) were enrolled in this study and they were categorized as with and without prostate inflammation. Quant...
The urine mtDNA-79 and mtDNA-230 were significantly increased in patients with prostate inflammation compared with those in without inflammation. Here, 79-bp fragment of apoptotic origin was significa...
Our results demonstrate that shorter cf-mtDNA fragment size in particular, increase in the presence of prostate inflammation in post-prostatic massage urine but both fragments could never improve seru...
To report outcomes within the Rapid Assessment for Prostate Imaging and Diagnosis (RAPID) diagnostic pathway, introduced to reduce patient and healthcare burdens and standardize delivery of pre-biopsy...
A total of 2130 patients from three centres who completed the RAPID pathway (3 April 2017 to 31 March 2020) were consecutively entered as a prospective registry. These patients were also compared to a...
The median patient age and PSA level were 66 years and 6.6 ng/mL, respectively. Biopsy could be omitted in 43% of patients (920/2130). A further 7.9% of patients (168/2130) declined a recommendation f...
The RAPID prostate cancer diagnostic pathway allows 43% of men to avoid a biopsy while preserving good detection of clinically significant cancers and low detection of insignificant cancers, although ...